Advanced Technologies for Disease Intervention: Innovations Across Precision Medicine, Nutrition and Holistic Therapies
Editat de Ranbir Chander Sobti, Aastha Sobti, Jagmohan Singh, Harpal S. Buttaren Limba Engleză Paperback – oct 2026
Volume Two then delves deeper into emerging technologies for disease intervention, focusing on drug development, delivery systems, nutrition, and natural products for health. Themes explored here include: developments and trends in drug discovery; drug repurposing; contemporary drug delivery systems; phototherapeutics; personalized drug delivery; innovations in vaccine development; the role of nutraceuticals in disease prevention; and the use of natural products and herbal interventions for sustainable health.
- Provides an in-depth compendium of emerging biotechnological therapies and diagnostic innovations, covering the latest advances in molecular medicine and biopharmaceutical research
- Delivers interdisciplinary perspectives, fostering collaboration across various research fields to enhance patient care strategies
- Considers both traditional therapies and cutting-edge innovations in the pursuit of sustainable health, from yoga practices, nutraceuticals and natural supplements, to AI, regenerative medicine, recombinant antigens, and genome editing technologies
Preț: 1451.01 lei
Preț vechi: 2143.97 lei
-32% Precomandă
Puncte Express: 2177
Carte nepublicată încă
Livrare prin curier în România Precomanda se expediază când titlul devine disponibil.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Specificații
ISBN-13: 9780443440335
ISBN-10: 0443440336
Pagini: 1200
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0443440336
Pagini: 1200
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Cuprins
VOLUME 1: INTEGRATING MODERN HEALTH TECHNOLOGIES AND TRADITIONAL THERAPIES TO PROMOTE GOOD HEALTH
SECTION 1: BIOTECHNOLOGICAL INNOVATIONS FOR SUSTAINABLE DEVELOPMENT TOWARDS GOOD HEALTH CARE SYSTEM
1. ADVANCED TECHNOLOGIES FOR DISEASE INTERVENTION: INNOVATIONS ACROSS PRECISION MEDICINE
2. EMERGING APTAMER DIAGNOSTICS: NEXT GEN POINT-OF-CARE (POC) TECHNOLOGY
3. ROLE OF APTAMERS IN MOLECULAR MEDICINE
4. CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) AND BEYOND: REVOLUTIONIZING PRECISION MEDICINE AND GENETIC THERAPIES
5. BIOSIMILARS IN CONTEMPORARY MEDICINE: FROM MOLECULAR DESIGN TO GLOBAL CLINICAL TRANSLATION
6. SWEET SITE OF RNA : DISCOVERY AND IMPLICATION OF GLYCO RNA IN HEALTH AND DISEASE
7. THE ROLE OF ER STRESS IN DISEASE AND IN THERAPEUTIC INTERACTION
SECTION 2: POTENTIAL OF STEM CELLS AND REGENERATIVE MEDICINE
8. ADULT STEM CELLS AND APPLICATIONS
9. EMBRYONIC STEM CELL RESEARCH: SCIENTIFIC ADVANCES AND BIOETHICAL CHALLENGES
10. ORGANOIDS AND LAB-GROWN TISSUES: A NEW FRONTIER IN DISEASE MODELING AND REGENERATIVE MEDICINE
11. 3D BIOPRINTING AND TISSUE ENGINEERING: BUILDING THE FUTURE OF TRANSPLANTATION
12. ADVANCEMENTS IN HUMAN-BASED BIOMATERIALS FOR 3D BIOPRINTING TECHNOLOGIES
13. POTENTIAL ROLE OF 3D-BIOPRINTING OF RECAPITULATED ORGANS AND TISSUES IN MODERN MEDICINE: AN OVERVIEW OF CARDIOVASCULAR DISEASES, CANCER, AND NON-CANCER APPLICATIONS
SECTION 3: ARTIFICIAL INTELLIGENCE & MACHINE LEARNING IN HEALTHCARE
14. ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN MICROBIAL DECIPHERING
15. ARTIFICIAL INTELLIGENCE IN CLINICAL DIAGNOSTICS AND DECISION MAKING
16. MODELING AND PREDICTING TO UNDERSTAND INFECTIOUS DISEASE TRANSMISSION
17. THE FUTURE OF HEALING: AI-DRIVEN PRECISION MEDICINE FOR PERSONALIZED HEALTH CARE
18. MOLECULAR EPIDEMIOLOGICAL APPROACH IN DISEASE MANAGEMENT
SECTION 4: MOLECULAR INSIGHTS AND ADVANCED THERAPEUTICS IN DISEASE MANAGEMENT
19. MAPPING MECHANISMS OF METASTASIS AND METABOLISM: ADVANCES IN UNDERSTANDING THE COMPLEXITY OF THETUMOR MICROENVIRONMENT
20. MOLECULAR PATHOPHYSIOLOGY OF STROKE: MECHANISTIC INSIGHTS, BIOMARKERS, AND EMERGING THERAPEUTIC TARGETS
21. PHARMACOTHERAPY OF HEART FAILURE: CURRENT TRENDS AND FUTURE DIRECTIONS
22. MOLECULAR INTERVENTIONS IN HEART FAILURE: GENE EDITING AND GENE THERAPY
23. ARRHYTHMIA-INDUCED SUDDEN CARDIAC DEATH: INSIGHTS AND PROSPECTS ON PATHOPHYSIOLOGY, BIOMARKERS, AND THERAPEUTIC STRATEGIES
24. ADVANCED STRATEGIES FOR DETECTION AND TREATMENT OF HIGH-RISK ATHEROSCLEROTIC PLAQUES: THE ROLE OF SINGLE-CELL RNA SEQUENCING
SECTION 5: NANOTECHNOLOGY AND BIOMATERIALS IN MODERN MEDICINE
25. PIONEERING ALZHEIMER'S DISEASE THERAPIES: INSIGHTS INTO PRECISION MEDICINE, NANOTHERAPEUTICS, AND STEM CELL INNOVATIONS
26. EVOLVING PARADIGMS IN ALZHEIMER'S DISEASE: FROM PATHOGENESIS TO PRECISION THERAPIES
SECTION 6: MICROBIOME, MENTAL HEALTH, AND INTEGRATIVE DISEASE MANAGEMENT
27. MICROBIOME MEDICINE: THE GUT-IMMUNE-BRAIN AXIS IN HEALTH AND DISEASE
28. THE CRUCIAL ROLES OF GUT MICROBIOTA IN THE DEVELOPMENT OF NON-COMMUNICABLE DISEASES WITH SPECIAL FOCUS ON THE EFFICACY OF PROBIOTICS AND BOVINE COLOSTRUM IN THE MANAGEMENT OF GASTROINTESTINAL DISORDERS IN ADULTS AND CHILDREN
29. THE PATHOPHYSIOLOGICAL RELATIONSHIP BETWEEN DIABETES MELLITUS AND ALZHEIMER’S DISEASE AND MANAGEMENT WITH HERBAL REMEDIES: AN OVERVIEW OF PRECLINICAL AND CLINICAL STUDIES.
30. EPIGENOME, NUTRIGENOME: IMPLICATIONS IN EVOLUTION OF TYPE 2 DIABETES
31. INSIGHTS INTO THE COMPLEXITIES OF DEMENTIA: DIAGNOSIS, THERAPEUTICS AND CURRENT RESEARCH
32. COGNITIVE DECLINE AND DEMENTIA IN ELDERLY HUMANS: HOLISTIC APPROACHES FOR THE PREVENTION AND MANAGEMENT OF NEURODEGENERATIVE DISEASES AND PSYCHIATRIC DISORDERS
33. REVOLUTIONIZING DENTAL CARE: A NEW ERA OF PRECISION, PERSONALIZATION, AND INNOVATION
34. OSTEOPOROSIS AS A PUBLIC HEALTH PROBLEM
35. INTEGRATIVE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) THROUGH YOGIC INTERVENTIONS
36. CHALLENGES IN THE EARLY DIAGNOSIS OF RESPIRATORY DISEASES AND POSSIBLE INTERVENTIONS
37. PRECISION MEDICINE IN ACUTE AND CHRONIC PANCREATITIS
38. KIDNEY DISEASE – INNOVATIONS AND SOLUTIONS
39. PATHOPHYSIOLOGY OF CHRONIC KIDNEY DISEASE: EPIDEMIOLOGY, DIAGNOSTICBIOMARKERS, AND MANAGEMENT WITH PROBIOTICS AND PREBIOTICS
40. CURRENT TRENDS AND CHALLENGES IN REPRODUCTIVE HEALTH ACROSS GENDERS
41. MALE BREAST CANCER: RARELY KNOWN DISEASE
RANBIR C. SOBTI SR. AND JAGMOHAN SINGH
VOLUME 2: STRATEGIES FOR COMBATING DISEASES THROUGH NEW THERAPEUTICS, DRUG DEVELOPMENT, NUTRITIONAL APPROACHES, NUTRITION, AND HOLISTIC THERAPIES
SECTION 1: INNOVATIONS IN DRUG DISCOVERY, DELIVERY SYSTEMS, AND REPURPOSING
42. CARRAGEENAN AND FUCOIDAN-BASED DELIVERY SYSTEMS FOR ORAL DELIVERY OF POLYPHENOLS: A REVIEW
43. RECENT DEVELOPMENTS AND EMERGING TRENDS IN DRUG DISCOVERY
44. EXPLORING NEW APPLICATIONS OF EXISTING DRUGS IN CANCER THERAPY
45. INNOVATIONS IN NANOTECHNOLOGY FOR TARGETED DRUG DELIVERY IN CANCER PATIENTS
46. NANOTECHNOLOGY-STEERED APPROACHES IN THE FIELD OF PHYTOPHARMACEUTICALS: ENHANCED BIOAVAILABILITY, THERAPEUTIC VALUE AND SITE-SPECIFIC TARGETING
47. NANOMATERIALS: TYPES, CHARACTERIZATION METHODS, MECHANISMS AS ANTIMICROBIALS- A REVIEW
48. NANOMATERIAL AS ANTI-MALARIAL DRUG CARRIERS FOR THE EFFECTIVE TREATMENT OF MALARIA
49. COMPOSITE LRP AND VGG NETWORKS FOR BRAIN TUMOR ANALYSIS
50. VOL 2, CH 9: COMPARATIVE ANALYSIS OF CNN AND TRANSFORMER ARCHITECTURES FOR MELANOMA DETECTION USING DERMOSCOPIC IMAGES
51. VOL 2, CH 10: BIONANOCOMPOSITES IN ANTI-INFLAMMATORY ACTIVITY
52. VOL 2, CH 11: SCANDIUM-LABELED PET RADIOPHARMACEUTICALS IN RADIOTHERANOSTICS: PRECLINICAL INSIGHTS AND CLINICAL PERSPECTIVES
SECTION 2: ADVANCES IN VACCINES AND IMMUNOTHERAPIES
53. EMERGING VACCINE TECHNOLOGIES: REVOLUTIONIZING THE PREVENTION OF PANDEMICS
54. MRNA VACCINE TECHNOLOGY: THE NEW ERA OF INFECTIOUS DISEASE CONTROL AND CANCER IMMUNOTHERAPY
55. VACCINE-BASED THERAPEUTIC INTERVENTIONS IN UVEAL MELANOMA MANAGEMENT: A CONCEPTUAL REVIEW
56. EDIBLE VACCINES AND HUMAN HEALTH: REALITY AND PREDICTIONS
57. TYPHOID VACCINES: THE ROADWAY TO EFFECTIVE CONTROL
58. REWIRING THE IMMUNE SYSTEM: ROLE OF CAR-T CELLS IN CANCER TREATMENT
59. TUNING YAYS-NAYS FOR CHIMERIC ANTIGEN RECEPTOR BASED CANCER IMMUNOTHERAPY EFFICACY
SECTION 3 : FUNCTIONAL FOODS, NUTRITION, AND CHRONIC DISEASE MANAGEMENT
60. PALUDICULTURE: A SOURCE OF POLYPHENOLS FOR CLINICAL NUTRITION AND FAVOURABLE CARBON FOOTPRINT
61. SECONDARY METABOLITES LIKE FLAVONOIDS USED FOR CANCER TREATMENT: RECENT TRENDS AND FUTURE PERSPECTIVES
62. DEVELOPMENT OF PHYTOCHEMICAL-BASED FOOD PRODUCTS FOR THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES
63. THE FUTURE OF PROTEIN SECURITY: AN OVERVIEW OF POTENTIAL ALTERNATIVES TO NON-ANIMAL PROTEIN SOURCES
64. THE FARM-TO-FORK STRATEGY: FROM PRODUCTION AND MANUFACTURING TO SUSTAINABLE HEALTHYFOOD SUPPLY
65. THE FUTURE OF FOODS: ALTERNATIVE PROTEIN SOURCES
66. NUTRITIONAL AND THERAPEUTIC BENEFITS OF MILLETS IN HEALTH AND DISEASE: A SYSTEMATIC REVIEW FOR PREVENTING NON-COMMUNICABLE DISEASES
67. THE ROLE OF FUNCTIONAL FOODS, PLANT PROTEINS, AND OILSEEDS IN NUTRITIONAL STRATEGIES FOR DISEASE PREVENTION: AN OVERVIEW
68. PROBIOTICS FROM TRADITIONAL AND CLINICAL PROSPECTIVES
69. THE ROLE OF PROBIOTICS IN CANCER PREVENTION AND TREATMENT
SECTION 4 : MARINE AND MICROBIAL RESOURCES FOR HEALTH AND WELL-BEING
70. HARVESTING THE BOUNTY OF THE SEAS FOR SUSTAINABLE FOOD SUPPLY, DIETARY SUPPLEMENTS, NUTRACEUTICALS, AND MEDICINAL INGREDIENTS
71. GLOBALLY SUSTAINABLE PRODUCTS OF SEA ORIGIN FOR HEALTH PROMOTION AND DISEASE PREVENTION: AN OVERVIEW ON THE DISCOVERY OF MARINE-DERIVED FOODS AND NUTRACEUTICALS
SECTION 5 : HERBAL MEDICINE, NATURAL COMPOUNDS, AND INTEGRATIVE THERAPIES
72. HERBAL INTERVENTIONS FOR THE TREATMENT OF ALCOHOL ADDICTION
73. NATURAL PRODUCTS-BASED NIOSOMAL ANTI-CANCER FORMULATIONS: RECENT TRENDS AND FUTURE PERSPECTIVES
74. BIOLOGICAL ACTIVITIES OF ERIGERON ANNUS AND NERIUM INDICUM
75. BIOLOGICAL ACTIVITIES OF RUMEX NEPALENSIS AND HEDYCHIUM SPICATUM ERIGERON ANNUS AND NERIUM INDICUM
76. AN OVERVIEW OF THE PAST, PRESENT, AND FUTURE OF NATURAL ANTICANCER MEDICINES DERIVED FROM PLANTS AND MARINE SOURCES: EFFICACY, SAFETY, AND MECHANISMS
SECTION 1: BIOTECHNOLOGICAL INNOVATIONS FOR SUSTAINABLE DEVELOPMENT TOWARDS GOOD HEALTH CARE SYSTEM
1. ADVANCED TECHNOLOGIES FOR DISEASE INTERVENTION: INNOVATIONS ACROSS PRECISION MEDICINE
2. EMERGING APTAMER DIAGNOSTICS: NEXT GEN POINT-OF-CARE (POC) TECHNOLOGY
3. ROLE OF APTAMERS IN MOLECULAR MEDICINE
4. CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) AND BEYOND: REVOLUTIONIZING PRECISION MEDICINE AND GENETIC THERAPIES
5. BIOSIMILARS IN CONTEMPORARY MEDICINE: FROM MOLECULAR DESIGN TO GLOBAL CLINICAL TRANSLATION
6. SWEET SITE OF RNA : DISCOVERY AND IMPLICATION OF GLYCO RNA IN HEALTH AND DISEASE
7. THE ROLE OF ER STRESS IN DISEASE AND IN THERAPEUTIC INTERACTION
SECTION 2: POTENTIAL OF STEM CELLS AND REGENERATIVE MEDICINE
8. ADULT STEM CELLS AND APPLICATIONS
9. EMBRYONIC STEM CELL RESEARCH: SCIENTIFIC ADVANCES AND BIOETHICAL CHALLENGES
10. ORGANOIDS AND LAB-GROWN TISSUES: A NEW FRONTIER IN DISEASE MODELING AND REGENERATIVE MEDICINE
11. 3D BIOPRINTING AND TISSUE ENGINEERING: BUILDING THE FUTURE OF TRANSPLANTATION
12. ADVANCEMENTS IN HUMAN-BASED BIOMATERIALS FOR 3D BIOPRINTING TECHNOLOGIES
13. POTENTIAL ROLE OF 3D-BIOPRINTING OF RECAPITULATED ORGANS AND TISSUES IN MODERN MEDICINE: AN OVERVIEW OF CARDIOVASCULAR DISEASES, CANCER, AND NON-CANCER APPLICATIONS
SECTION 3: ARTIFICIAL INTELLIGENCE & MACHINE LEARNING IN HEALTHCARE
14. ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN MICROBIAL DECIPHERING
15. ARTIFICIAL INTELLIGENCE IN CLINICAL DIAGNOSTICS AND DECISION MAKING
16. MODELING AND PREDICTING TO UNDERSTAND INFECTIOUS DISEASE TRANSMISSION
17. THE FUTURE OF HEALING: AI-DRIVEN PRECISION MEDICINE FOR PERSONALIZED HEALTH CARE
18. MOLECULAR EPIDEMIOLOGICAL APPROACH IN DISEASE MANAGEMENT
SECTION 4: MOLECULAR INSIGHTS AND ADVANCED THERAPEUTICS IN DISEASE MANAGEMENT
19. MAPPING MECHANISMS OF METASTASIS AND METABOLISM: ADVANCES IN UNDERSTANDING THE COMPLEXITY OF THETUMOR MICROENVIRONMENT
20. MOLECULAR PATHOPHYSIOLOGY OF STROKE: MECHANISTIC INSIGHTS, BIOMARKERS, AND EMERGING THERAPEUTIC TARGETS
21. PHARMACOTHERAPY OF HEART FAILURE: CURRENT TRENDS AND FUTURE DIRECTIONS
22. MOLECULAR INTERVENTIONS IN HEART FAILURE: GENE EDITING AND GENE THERAPY
23. ARRHYTHMIA-INDUCED SUDDEN CARDIAC DEATH: INSIGHTS AND PROSPECTS ON PATHOPHYSIOLOGY, BIOMARKERS, AND THERAPEUTIC STRATEGIES
24. ADVANCED STRATEGIES FOR DETECTION AND TREATMENT OF HIGH-RISK ATHEROSCLEROTIC PLAQUES: THE ROLE OF SINGLE-CELL RNA SEQUENCING
SECTION 5: NANOTECHNOLOGY AND BIOMATERIALS IN MODERN MEDICINE
25. PIONEERING ALZHEIMER'S DISEASE THERAPIES: INSIGHTS INTO PRECISION MEDICINE, NANOTHERAPEUTICS, AND STEM CELL INNOVATIONS
26. EVOLVING PARADIGMS IN ALZHEIMER'S DISEASE: FROM PATHOGENESIS TO PRECISION THERAPIES
SECTION 6: MICROBIOME, MENTAL HEALTH, AND INTEGRATIVE DISEASE MANAGEMENT
27. MICROBIOME MEDICINE: THE GUT-IMMUNE-BRAIN AXIS IN HEALTH AND DISEASE
28. THE CRUCIAL ROLES OF GUT MICROBIOTA IN THE DEVELOPMENT OF NON-COMMUNICABLE DISEASES WITH SPECIAL FOCUS ON THE EFFICACY OF PROBIOTICS AND BOVINE COLOSTRUM IN THE MANAGEMENT OF GASTROINTESTINAL DISORDERS IN ADULTS AND CHILDREN
29. THE PATHOPHYSIOLOGICAL RELATIONSHIP BETWEEN DIABETES MELLITUS AND ALZHEIMER’S DISEASE AND MANAGEMENT WITH HERBAL REMEDIES: AN OVERVIEW OF PRECLINICAL AND CLINICAL STUDIES.
30. EPIGENOME, NUTRIGENOME: IMPLICATIONS IN EVOLUTION OF TYPE 2 DIABETES
31. INSIGHTS INTO THE COMPLEXITIES OF DEMENTIA: DIAGNOSIS, THERAPEUTICS AND CURRENT RESEARCH
32. COGNITIVE DECLINE AND DEMENTIA IN ELDERLY HUMANS: HOLISTIC APPROACHES FOR THE PREVENTION AND MANAGEMENT OF NEURODEGENERATIVE DISEASES AND PSYCHIATRIC DISORDERS
33. REVOLUTIONIZING DENTAL CARE: A NEW ERA OF PRECISION, PERSONALIZATION, AND INNOVATION
34. OSTEOPOROSIS AS A PUBLIC HEALTH PROBLEM
35. INTEGRATIVE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) THROUGH YOGIC INTERVENTIONS
36. CHALLENGES IN THE EARLY DIAGNOSIS OF RESPIRATORY DISEASES AND POSSIBLE INTERVENTIONS
37. PRECISION MEDICINE IN ACUTE AND CHRONIC PANCREATITIS
38. KIDNEY DISEASE – INNOVATIONS AND SOLUTIONS
39. PATHOPHYSIOLOGY OF CHRONIC KIDNEY DISEASE: EPIDEMIOLOGY, DIAGNOSTICBIOMARKERS, AND MANAGEMENT WITH PROBIOTICS AND PREBIOTICS
40. CURRENT TRENDS AND CHALLENGES IN REPRODUCTIVE HEALTH ACROSS GENDERS
41. MALE BREAST CANCER: RARELY KNOWN DISEASE
RANBIR C. SOBTI SR. AND JAGMOHAN SINGH
VOLUME 2: STRATEGIES FOR COMBATING DISEASES THROUGH NEW THERAPEUTICS, DRUG DEVELOPMENT, NUTRITIONAL APPROACHES, NUTRITION, AND HOLISTIC THERAPIES
SECTION 1: INNOVATIONS IN DRUG DISCOVERY, DELIVERY SYSTEMS, AND REPURPOSING
42. CARRAGEENAN AND FUCOIDAN-BASED DELIVERY SYSTEMS FOR ORAL DELIVERY OF POLYPHENOLS: A REVIEW
43. RECENT DEVELOPMENTS AND EMERGING TRENDS IN DRUG DISCOVERY
44. EXPLORING NEW APPLICATIONS OF EXISTING DRUGS IN CANCER THERAPY
45. INNOVATIONS IN NANOTECHNOLOGY FOR TARGETED DRUG DELIVERY IN CANCER PATIENTS
46. NANOTECHNOLOGY-STEERED APPROACHES IN THE FIELD OF PHYTOPHARMACEUTICALS: ENHANCED BIOAVAILABILITY, THERAPEUTIC VALUE AND SITE-SPECIFIC TARGETING
47. NANOMATERIALS: TYPES, CHARACTERIZATION METHODS, MECHANISMS AS ANTIMICROBIALS- A REVIEW
48. NANOMATERIAL AS ANTI-MALARIAL DRUG CARRIERS FOR THE EFFECTIVE TREATMENT OF MALARIA
49. COMPOSITE LRP AND VGG NETWORKS FOR BRAIN TUMOR ANALYSIS
50. VOL 2, CH 9: COMPARATIVE ANALYSIS OF CNN AND TRANSFORMER ARCHITECTURES FOR MELANOMA DETECTION USING DERMOSCOPIC IMAGES
51. VOL 2, CH 10: BIONANOCOMPOSITES IN ANTI-INFLAMMATORY ACTIVITY
52. VOL 2, CH 11: SCANDIUM-LABELED PET RADIOPHARMACEUTICALS IN RADIOTHERANOSTICS: PRECLINICAL INSIGHTS AND CLINICAL PERSPECTIVES
SECTION 2: ADVANCES IN VACCINES AND IMMUNOTHERAPIES
53. EMERGING VACCINE TECHNOLOGIES: REVOLUTIONIZING THE PREVENTION OF PANDEMICS
54. MRNA VACCINE TECHNOLOGY: THE NEW ERA OF INFECTIOUS DISEASE CONTROL AND CANCER IMMUNOTHERAPY
55. VACCINE-BASED THERAPEUTIC INTERVENTIONS IN UVEAL MELANOMA MANAGEMENT: A CONCEPTUAL REVIEW
56. EDIBLE VACCINES AND HUMAN HEALTH: REALITY AND PREDICTIONS
57. TYPHOID VACCINES: THE ROADWAY TO EFFECTIVE CONTROL
58. REWIRING THE IMMUNE SYSTEM: ROLE OF CAR-T CELLS IN CANCER TREATMENT
59. TUNING YAYS-NAYS FOR CHIMERIC ANTIGEN RECEPTOR BASED CANCER IMMUNOTHERAPY EFFICACY
SECTION 3 : FUNCTIONAL FOODS, NUTRITION, AND CHRONIC DISEASE MANAGEMENT
60. PALUDICULTURE: A SOURCE OF POLYPHENOLS FOR CLINICAL NUTRITION AND FAVOURABLE CARBON FOOTPRINT
61. SECONDARY METABOLITES LIKE FLAVONOIDS USED FOR CANCER TREATMENT: RECENT TRENDS AND FUTURE PERSPECTIVES
62. DEVELOPMENT OF PHYTOCHEMICAL-BASED FOOD PRODUCTS FOR THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES
63. THE FUTURE OF PROTEIN SECURITY: AN OVERVIEW OF POTENTIAL ALTERNATIVES TO NON-ANIMAL PROTEIN SOURCES
64. THE FARM-TO-FORK STRATEGY: FROM PRODUCTION AND MANUFACTURING TO SUSTAINABLE HEALTHYFOOD SUPPLY
65. THE FUTURE OF FOODS: ALTERNATIVE PROTEIN SOURCES
66. NUTRITIONAL AND THERAPEUTIC BENEFITS OF MILLETS IN HEALTH AND DISEASE: A SYSTEMATIC REVIEW FOR PREVENTING NON-COMMUNICABLE DISEASES
67. THE ROLE OF FUNCTIONAL FOODS, PLANT PROTEINS, AND OILSEEDS IN NUTRITIONAL STRATEGIES FOR DISEASE PREVENTION: AN OVERVIEW
68. PROBIOTICS FROM TRADITIONAL AND CLINICAL PROSPECTIVES
69. THE ROLE OF PROBIOTICS IN CANCER PREVENTION AND TREATMENT
SECTION 4 : MARINE AND MICROBIAL RESOURCES FOR HEALTH AND WELL-BEING
70. HARVESTING THE BOUNTY OF THE SEAS FOR SUSTAINABLE FOOD SUPPLY, DIETARY SUPPLEMENTS, NUTRACEUTICALS, AND MEDICINAL INGREDIENTS
71. GLOBALLY SUSTAINABLE PRODUCTS OF SEA ORIGIN FOR HEALTH PROMOTION AND DISEASE PREVENTION: AN OVERVIEW ON THE DISCOVERY OF MARINE-DERIVED FOODS AND NUTRACEUTICALS
SECTION 5 : HERBAL MEDICINE, NATURAL COMPOUNDS, AND INTEGRATIVE THERAPIES
72. HERBAL INTERVENTIONS FOR THE TREATMENT OF ALCOHOL ADDICTION
73. NATURAL PRODUCTS-BASED NIOSOMAL ANTI-CANCER FORMULATIONS: RECENT TRENDS AND FUTURE PERSPECTIVES
74. BIOLOGICAL ACTIVITIES OF ERIGERON ANNUS AND NERIUM INDICUM
75. BIOLOGICAL ACTIVITIES OF RUMEX NEPALENSIS AND HEDYCHIUM SPICATUM ERIGERON ANNUS AND NERIUM INDICUM
76. AN OVERVIEW OF THE PAST, PRESENT, AND FUTURE OF NATURAL ANTICANCER MEDICINES DERIVED FROM PLANTS AND MARINE SOURCES: EFFICACY, SAFETY, AND MECHANISMS